MedPath

A study to see the alertness of mind in terms of sleepiness when exposed to white LED or daily using domestic white LED in healthy adults.

Not Applicable
Registration Number
CTRI/2022/09/045603
Lead Sponsor
Mousumi Ghosh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. age between 18 to 35 years include both male and female

2. literate

3. basic English proficiency

4. regular sleep schedule for 7 to 8 hours where bedtime 10 to 11 pm and wakeup time 6 to 7 am IST

5. global PSQI score less than or equal to 5

6. refractive error with corrected distance VA better than or equal to 20/25 with a healthy retina

Exclusion Criteria

1. any ocular pathology

2. any psychological and neurological disorders, intake of drugs, smoking, alcoholism, intake of caffeine >2 cups/day or >400 mg/day

3. any systemic illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
i.Sleep score using Global PSQI scoring (Good sleep indicates PSQI less than 5 and Poor sleep greater than 5) <br/ ><br>ii.Cognitive test using Mini-Cog (quantitative) (Normal: Score 3-5; Cognitive impairment: Score 0-2) <br/ ><br>iii.Pre-frontal cortical responses using ERP (target P300 amplitude in �µV and P300 latency in msec) while performing N-back task when exposed to white LED (in lux). <br/ ><br>iv.Protective efficacy of blue light blocking lenses I, II, and Placebo lens III when exposed to white LED. <br/ ><br>Timepoint: 30 minutes of White LED exposure and 30 minutes of White LED washout using Amber LED.
Secondary Outcome Measures
NameTimeMethod
i. Protective efficacy of blue light blocking lenses I (Crizal Prevenncia), II (DuraVision BlueProtect), and Placebo lens III (Untinted) when exposed to white LED.Timepoint: 30 minutes of exposure to white LED with each blue-blocking lens.
© Copyright 2025. All Rights Reserved by MedPath